These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 35970432)

  • 1. Emerging therapies targeting eosinophil-mediated inflammation in chronic allergic conjunctivitis.
    Fernandez A; Asbell P; Roy N
    Ocul Surf; 2022 Oct; 26():191-196. PubMed ID: 35970432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lirentelimab for severe and chronic forms of allergic conjunctivitis.
    Anesi SD; Tauber J; Nguyen QD; Chang P; Berdy GJ; Lin CC; Chu DS; Levine HT; Fernandez AD; Roy N; Asbell PA; Kantor AM; Chang AT; Singh B; Youngblood BA; Jeng BH; Jhanji V; Rasmussen HS; Foster CS
    J Allergy Clin Immunol; 2022 Sep; 150(3):631-639. PubMed ID: 35390403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent patents and emerging therapeutics in the treatment of allergic conjunctivitis.
    Mishra GP; Tamboli V; Jwala J; Mitra AK
    Recent Pat Inflamm Allergy Drug Discov; 2011 Jan; 5(1):26-36. PubMed ID: 21171952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eosinophil surface antigen expression and cytokine production vary in different ocular allergic diseases.
    Hingorani M; Calder V; Jolly G; Buckley RJ; Lightman SL
    J Allergy Clin Immunol; 1998 Nov; 102(5):821-30. PubMed ID: 9819300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tear levels of interferon-gamma, interleukin (IL) -2, IL-4 and IL-5 in patients with vernal keratoconjunctivitis, atopic keratoconjunctivitis and allergic conjunctivitis.
    Uchio E; Ono SY; Ikezawa Z; Ohno S
    Clin Exp Allergy; 2000 Jan; 30(1):103-9. PubMed ID: 10606937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular allergy test and biomarkers on the ocular surface: Clinical test for evaluating the ocular surface condition in allergic conjunctival diseases.
    Shoji J
    Allergol Int; 2020 Oct; 69(4):496-504. PubMed ID: 32563624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vernal keratoconjunctivitis: An update.
    Ghiglioni DG; Zicari AM; Parisi GF; Marchese G; Indolfi C; Diaferio L; Brindisi G; Ciprandi G; Marseglia GL; Miraglia Del Giudice M
    Eur J Ophthalmol; 2021 Nov; 31(6):2828-2842. PubMed ID: 34058899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating the ocular component of allergic rhinoconjunctivitis and related eye disorders.
    Bielory L; Katelaris CH; Lightman S; Naclerio RM
    MedGenMed; 2007 Aug; 9(3):35. PubMed ID: 18092041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vernal keratoconjunctivitis: a severe allergic eye disease with remodeling changes.
    Vichyanond P; Pacharn P; Pleyer U; Leonardi A
    Pediatr Allergy Immunol; 2014 Jun; 25(4):314-22. PubMed ID: 24438133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular allergy guidelines: a practical treatment algorithm.
    Bielory L
    Drugs; 2002; 62(11):1611-34. PubMed ID: 12109924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allergy and the eye.
    Leonardi A; Motterle L; Bortolotti M
    Clin Exp Immunol; 2008 Sep; 153 Suppl 1(Suppl 1):17-21. PubMed ID: 18721324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tear cytokines in acute and chronic ocular allergic inflammation.
    Cook EB
    Curr Opin Allergy Clin Immunol; 2004 Oct; 4(5):441-5. PubMed ID: 15349046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tear and serum soluble leukocyte activation markers in conjunctival allergic diseases.
    Leonardi A; Borghesan F; Faggian D; Depaoli M; Secchi AG; Plebani M
    Am J Ophthalmol; 2000 Feb; 129(2):151-8. PubMed ID: 10682966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current aspects of vernal and atopic keratoconjunctivitis].
    Messmer EM; Priglinger SG; Kassumeh S
    Ophthalmologie; 2024 Mar; 121(3):173-179. PubMed ID: 38334798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic criteria of chronic conjunctivitis: atopic keratoconjunctivitis and vernal keratoconjunctivitis.
    Leonardi A; Righetti G; Giovannini G; De Marchi V; Occhiuto M
    Curr Opin Allergy Clin Immunol; 2023 Oct; 23(5):390-396. PubMed ID: 37284778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical therapy for ocular allergy.
    Trocme SD; Raizman MB; Bartley GB
    Mayo Clin Proc; 1992 Jun; 67(6):557-65. PubMed ID: 1359206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atopic keratoconjunctivitis.
    Bonini S
    Allergy; 2004 Aug; 59 Suppl 78():71-3. PubMed ID: 15245362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The differences of tear function and ocular surface findings in patients with atopic keratoconjunctivitis and vernal keratoconjunctivitis.
    Hu Y; Matsumoto Y; Dogru M; Okada N; Igarashi A; Fukagawa K; Tsubota K; Fujishima H
    Allergy; 2007 Aug; 62(8):917-25. PubMed ID: 17620070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular allergic disease.
    Stahl JL; Barney NP
    Curr Opin Allergy Clin Immunol; 2004 Oct; 4(5):455-9. PubMed ID: 15349048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biologics for allergy: therapeutic potential for ocular allergic diseases and adverse effects on the eye.
    Fukuda K; Kishimoto T; Sumi T; Yamashiro K; Ebihara N
    Allergol Int; 2023 Apr; 72(2):234-244. PubMed ID: 36333219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.